Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Communicable Diseases Intelligence (2018)
|
April 18, 2020
Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia
Peter Wnukowski-Mtonga, Sanjay Jayasinghe, Clayton Chiu, et al.
Communicable Diseases Intelligence (2018)
|
July 18, 2024
ATAGI targeted review 2023: Vaccination for preventing influenza in Australia
Chisato Imai, Sanjay Jayasinghe, Jocelynne McRae, et al.
The Lancet Regional Health. Western Pacific
|
February 2, 2026
Prevalence and serotype distribution of nasopharyngeal carriage of <i>Streptococcus pneumoniae</i> in Vietnam: a systematic review and meta-analysis
Xuanchen Tao, Ketaki Sharma, Catherine King, et al.
Communicable Diseases Intelligence (2018)
|
May 25, 2026
ATAGI Targeted Review 2024: Immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia
Chisato Imai-Boulter, Jean Li-Kim-Moy, Jocelynne McRae, et al.
Communicable Diseases Intelligence Quarterly Report
|
March 22, 2011
Vaccine preventable diseases in Australia, 2005 to 2007
Clayton Chiu, Aditi Dey, Han Wang, et al.
Open Forum Infectious Diseases
|
June 24, 2026
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Phoebe C M Williams, Annaleise Howard Jones, Robert Duguid, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
The Journal of Infection
|
January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Yangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases
|
December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis
Julia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms
|
April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Julia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Communicable Diseases Intelligence (2018)
|
April 18, 2020
Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia
Peter Wnukowski-Mtonga, Sanjay Jayasinghe, Clayton Chiu, et al.
Communicable Diseases Intelligence (2018)
|
July 18, 2024
ATAGI targeted review 2023: Vaccination for preventing influenza in Australia
Chisato Imai, Sanjay Jayasinghe, Jocelynne McRae, et al.
The Lancet Regional Health. Western Pacific
|
February 2, 2026
Prevalence and serotype distribution of nasopharyngeal carriage of <i>Streptococcus pneumoniae</i> in Vietnam: a systematic review and meta-analysis
Xuanchen Tao, Ketaki Sharma, Catherine King, et al.
Communicable Diseases Intelligence (2018)
|
May 25, 2026
ATAGI Targeted Review 2024: Immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia
Chisato Imai-Boulter, Jean Li-Kim-Moy, Jocelynne McRae, et al.
Communicable Diseases Intelligence Quarterly Report
|
March 22, 2011
Vaccine preventable diseases in Australia, 2005 to 2007
Clayton Chiu, Aditi Dey, Han Wang, et al.
Open Forum Infectious Diseases
|
June 24, 2026
The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study
Phoebe C M Williams, Annaleise Howard Jones, Robert Duguid, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
The Journal of Infection
|
January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Yangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
The Lancet. Infectious Diseases
|
December 20, 2024
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis
Julia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, et al.
Microorganisms
|
April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Julia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
Page
of 5